Semaglutide
Characteristics:
Producer: Hilma Biocare
Class: Peptide hormone
Type: Injection/powder
Dosage: 2 mg/ml
Intake dosage: 0,5-1 mg a week
Packaging: Vial of 2mg
Active substance: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Base solution: Powder
Product Half-life: 5-7 days
Level of water retention: No
Aromatization: No
Product Overview
Semaglutide is a glucagon-like peptide-1 receptor agonist. It is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. Semaglutide is not for use in people with type 1 diabetes. Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in patients. The higher-dose formulation of Semaglutide is indicated as an adjunct to diet and exercise for long-term weight management in adults with obesity or who are overweight and have at least one weight-related comorbidity.
Potential Side Effects
You should not use Semaglutide if you have multiple endocrine neoplasia type 2 (tumors in the glands) or a personal or family history of medullary thyroid cancer.
Ask your doctor about taking Semaglutide if you have ever had the following diseases or conditions:
- Diabetic ketoacidosis
- Pancreatitis
- Kidney disease
- Eye problems caused by diabetes (retinopathy)
- Vomiting
- Diarrhea
- Allergic Reactions
Recommended Combinations
It can be combined Semaglutide with other drugs such as Metformin, Sulfonylureas, Insulin, DPP-4 Inhibitors, DPP-4 inhibitors, SGLT-2 Inhibitors, Triple Therapy.